FDA Inspection
Novartis Pharma Schweizerhalle AgNovartis Pharma Schweizerhalle Ag – FDA Inspection, Jul 14, 2015
Record Details
This FDA Inspection record concerns Novartis Pharma Schweizerhalle Ag, with an inspection on July 14, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- July 14, 2015
- Product Type
- Drugs
View Company Profile
ID · 32ece39a-6d27-4f5e-9dd8-69bdc335039a
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 938183
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Novartis Pharma Schweizerhalle Ag
7| Date | Classification | Office | Project area |
|---|---|---|---|
| March 27, 2025 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 25, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 5, 2019 | Not classified | Office of Inspections and Investigations | |
| June 23, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 25, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Novartis Pharma Schweizerhalle Ag
- FDA Inspection 1289844 - 2025-03-27
- FDA Inspection 1180967 - 2022-08-25
- FDA Inspection 1099107 - 2019-07-05
- FDA Inspection 1018347 - 2017-06-23
- FDA Inspection 810431 - 2012-09-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.